These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10485665)

  • 21. Guidance on rosiglitazone for type 2 diabetes mellitus.
    Matthews DR
    Lancet; 2001 Feb; 357(9254):481. PubMed ID: 11273100
    [No Abstract]   [Full Text] [Related]  

  • 22. New treatment for adult-onset diabetes.
    Zurlinden J
    Nurs Spectr (Wash D C); 1997 Aug; 7(16):8. PubMed ID: 9439332
    [No Abstract]   [Full Text] [Related]  

  • 23. Honing type 2 diabetes treatment.
    Blackburn G
    Health News; 2001 Jan; 7(1):1-2. PubMed ID: 11198405
    [No Abstract]   [Full Text] [Related]  

  • 24. [Glitazone--a new class of drugs for the treatment of type 2 diabetes].
    Algenstaedt P; Hamann A
    Dtsch Med Wochenschr; 2001 Aug; 126(34-35):951-2. PubMed ID: 11523019
    [No Abstract]   [Full Text] [Related]  

  • 25. Troglitazone.
    Santiago JV
    Compr Ther; 1997 Aug; 23(8):560-2. PubMed ID: 9283746
    [No Abstract]   [Full Text] [Related]  

  • 26. [Type 2 diabetes. A new kind of insulin sensitizer at the door].
    Böhm S
    MMW Fortschr Med; 1999 Jul; 141(27):56-7. PubMed ID: 10904588
    [No Abstract]   [Full Text] [Related]  

  • 27. [First insulin sensitizer approved in Germany. Insulin resistance in type 2 diabetes can be treated].
    MMW Fortschr Med; 2000 Sep; 142(36):50. PubMed ID: 11021073
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of type 2 diabetes. Blood lipids should not be neglected!].
    MMW Fortschr Med; 2000 Nov; 142(44):56. PubMed ID: 11107815
    [No Abstract]   [Full Text] [Related]  

  • 29. Pioglitazone: the future.
    Brunetti P
    Int J Clin Pract Suppl; 2001 Sep; (121):36. PubMed ID: 11594244
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular risk reduction with pioglitazone.
    Cardiovasc J S Afr; 2002; 13(4):218. PubMed ID: 12402932
    [No Abstract]   [Full Text] [Related]  

  • 31. Rosiglitazone.
    Goldstein BJ
    Int J Clin Pract; 2000 Jun; 54(5):333-7. PubMed ID: 10954962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Information on thiazolidinediones.
    Wolfe SM; Lurie P; Sasich LD; Barbehenn E
    Lancet; 2000 Jul; 356(9225):254-5. PubMed ID: 10963229
    [No Abstract]   [Full Text] [Related]  

  • 33. [New prospects for the type 2 diabetic patient. Delaying disease progression].
    MMW Fortschr Med; 2000 Nov; 142(46):56-7. PubMed ID: 11138590
    [No Abstract]   [Full Text] [Related]  

  • 34. Pioglitazone (Actos).
    Med Lett Drugs Ther; 1999 Nov; 41(1066):112. PubMed ID: 10987011
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vascular damage decides prognosis of type 2 diabetic patients. Lowering blood glucose is not enough].
    MMW Fortschr Med; 2002 May; 144(18):65. PubMed ID: 12422717
    [No Abstract]   [Full Text] [Related]  

  • 36. [Life expectancy decreased by 1/3rd. Who to sink the vascular risk of type 2 diabetic patients?].
    MMW Fortschr Med; 2001 Dec; 143(49-50):56. PubMed ID: 11808457
    [No Abstract]   [Full Text] [Related]  

  • 37. Pioglitazone and rosiglitazone for diabetes.
    Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Causal therapy of type 2 diabetes. Determining the cause of insulin resistance early].
    MMW Fortschr Med; 2000 Nov; 142(47):56. PubMed ID: 11143782
    [No Abstract]   [Full Text] [Related]  

  • 39. [Against insulin resistance. Insulin sensitizers].
    Verspohl EJ; Weiland F
    Pharm Unserer Zeit; 2002; 31(3):280-92. PubMed ID: 12071125
    [No Abstract]   [Full Text] [Related]  

  • 40. A miracle of salamization: positive divided by two equals negative.
    Iwamoto Y
    Diabet Med; 1997 Nov; 14(11):994. PubMed ID: 9400931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.